(A) If the state board of pharmacy establishes and maintains a drug database pursuant to section 4729.75 of the Revised Code, the board shall present a biennial report to the standing committees of the house of representatives and the senate that are primarily responsible for considering health and human services issues. The initial report shall be presented not later than two years after the database is established.
(B) Each report presented under this section shall include all of the following:
(1) The cost to the state of establishing and maintaining the database;
(2) Information from terminal distributors of dangerous drugs, prescribers, and the board regarding the board's effectiveness in providing information from the database;
(3) The board's timeliness in transmitting information from the database.
Renumbered by 129th General AssemblyFile No.19, HB 93, §1, eff. 5/20/2011.
Effective Date: 05-18-2005